Acura Pharmaceuticals, Inc
ACURDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000786947
Acura Pharmaceuticals, Inc was delisted in 2025; its insiders filed their last Form 4 on Jan 15, 2026; no institution reported holding it in 13F filings for Q4 2024; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Acura Pharmaceuticals, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Acura Pharmaceuticals, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Skelly William G | Director | 675,989 | Jan 15, 2026 | 1 |
| Ross George K | Director | 595,903 | Jan 15, 2026 | 1 |
| Thangaraj Immanuel | Director | 547,647 | Jan 15, 2026 | 1 |
| Wesson Bruce F | Director, Other: Director Emeritus | 829,548 | Jan 2, 2024 | 0 |
| Clemens Peter A | Senior VP & CFO | 545,430 | Nov 20, 2023 | 0 |
| Seiser Robert A | VP, Treasurer & Controller | 438,254 | Nov 20, 2023 | 0 |
| Jones Robert B | President & CEO | 643,555 | Nov 20, 2023 | 0 |
| Brzeczko Albert W | See Remarks | 486,001 | Nov 20, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.